Search

Author/Creator Solca, F.

1. 3084 Phase III trial of afatinib vs erlotinib in patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes. (September 2015)

Authors:
Goss, G.D.; Felip, E.; Cobo, M.; Lu, S.; Syrigos, K.; Li, K.W.; Zhou, C.; Park, K.; Solca, F.; Krämer, N.; Chand, V.K.; Soria, J.C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S626
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours. Issue 16 (November 2015)

Authors:
Suder, A.; Ang, J.E.; Kyle, F.; Harris, D.; Rudman, S.; Kristeleit, R.; Solca, F.; Uttenreuther-Fischer, M.; Pemberton, K.; Pelling, K.; Schnell, D.; de Bono, J.; Spicer, J.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 16(2015:Nov.)
Page Start:
2275
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer. (14th July 2017)

Authors:
Cohen, E. E. W.; Licitra, L. F.; Burtness, B.; Fayette, J.; Gauler, T.; Clement, P. M.; Grau, J. J.; del Campo, J. M.; Mailliez, A.; Haddad, R. I.; Vermorken, J. B.; Tahara, M.; Guigay, J.; Geoffrois, L.; Merlano, M. C.; Dupuis, N.; Krämer, N.; Cong, X. J.; Gibson, N.; Solca, F.
Journal:
Annals of oncology
Issue:
Volume 28:Number 10(2017)
Page Start:
2526
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CSF angiogenin levels in amyotrophic lateral Sclerosis-Frontotemporal dementia spectrum. Issue 1 (2nd January 2020)

Authors:
Morelli, C.; Tiloca, C.; Colombrita, C.; Zambon, A.; Soranna, D.; Lafronza, A.; Solca, F.; Carelli, L.; Poletti, B.; Doretti, A.; Verde, F.; Maderna, L.; Ticozzi, N.; Ratti, A.; Silani, V.
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 21:Issue 1/2(2020)
Page Start:
63
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders. (February 2017)

Authors:
Gadgeel, S.M.; Soria, J.C.; Felip, E.; Cobo, M.; Lu, S.; Syrigos, K.; Lee, K.H.; Göker, E.; Georgoulias, V.; Li, W.; Guclu, S.; Isla, D.; Ardizzoni, A.; Dupuis, N.; Gibson, N.; Krämer, N.; Bühnemann, C.; Solca, F.; Ehrnrooth, E.; Goss, G.
Journal:
European journal of cancer
Issue:
Volume 72(2017)Supplement 1
Page Start:
S185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗